Clinical Trial Update: The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating etanercept (Enbrel) for the treatment of acute graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Graft-Versus-Host Disease | Phase 2 | Status: COMPLETED